Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.


  • Repeating aloud to another person boosts recall

  • American placebo: New analysis of chronic pain drug trials shows increasing placebo responses over time, in the US only

  • Understanding others' thoughts enables young kids to lie

  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse

  • Benzodiazepines ineffective in treating anxiety disorders may increase dementia risk

  • Immigrants play increasing role in U.S. science, engineering workforce

  • Scientists identify how normally protective immune responses kill neurons